Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerie Powell

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Schizophrenia Research|June 8, 2014
Mean platelet volume in schizophrenia unaltered after 1year of clozapine exposureJimmy Lee, Valerie Powell, Gary Remington
The Journal of Clinical Psychiatry|August 25, 2015
Clozapine and anemia: a 2-year follow-up studyJimmy Lee, Robert Bies, Amaal Bhaloo, et al.
Schizophrenia Research|July 8, 2010
Determining rates of hepatitis C in a clozapine treated cohortSanjeev Sockalingam, Chekkera Shammi, Valerie Powell, et al.
Journal of Clinical Psychopharmacology|April 4, 2015
Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophreniaJimmy Lee, Gagan Fervaha, Hiroyoshi Takeuchi, et al.
Journal of Clinical Psychopharmacology|June 18, 2019
Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical ReviewMarie-Christine Noël, Valerie Powell, Leah Burton, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|June 29, 2022
Improving diversity in study participation: Patient perspectives on barriers, racial differences and the role of communitiesLisa Shea, Jacqueline Pesa, Gabrielle Geonnotti, et al.
Psychopharmacology|November 27, 2012
Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Gary Remington, Ofer Agid, George Foussias, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 27, 2014
Relationship between clinical improvement and functional gains with clozapine in schizophreniaJimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 5, 2024
Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensée et neurocognition dans la schizophrénie réfractaireMohammed Alarabi, Leah Burton, Valerie Powell, et al.
Schizophrenia Research|January 23, 2024
Safety of BEN guidelines in clozapine treatment: A Canadian perspectiveSally Wu, Valerie Powell, Araba Chintoh, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Schizophrenia Research|June 8, 2014
Mean platelet volume in schizophrenia unaltered after 1year of clozapine exposureJimmy Lee, Valerie Powell, Gary Remington
The Journal of Clinical Psychiatry|August 25, 2015
Clozapine and anemia: a 2-year follow-up studyJimmy Lee, Robert Bies, Amaal Bhaloo, et al.
Schizophrenia Research|July 8, 2010
Determining rates of hepatitis C in a clozapine treated cohortSanjeev Sockalingam, Chekkera Shammi, Valerie Powell, et al.
Journal of Clinical Psychopharmacology|April 4, 2015
Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophreniaJimmy Lee, Gagan Fervaha, Hiroyoshi Takeuchi, et al.
Journal of Clinical Psychopharmacology|June 18, 2019
Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical ReviewMarie-Christine Noël, Valerie Powell, Leah Burton, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|June 29, 2022
Improving diversity in study participation: Patient perspectives on barriers, racial differences and the role of communitiesLisa Shea, Jacqueline Pesa, Gabrielle Geonnotti, et al.
Psychopharmacology|November 27, 2012
Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Gary Remington, Ofer Agid, George Foussias, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 27, 2014
Relationship between clinical improvement and functional gains with clozapine in schizophreniaJimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 5, 2024
Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensée et neurocognition dans la schizophrénie réfractaireMohammed Alarabi, Leah Burton, Valerie Powell, et al.
Schizophrenia Research|January 23, 2024
Safety of BEN guidelines in clozapine treatment: A Canadian perspectiveSally Wu, Valerie Powell, Araba Chintoh, et al.
Pageof 2